Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Kalawalla Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Kalawalla Treatment Report

What is Kalawalla? Kalawalla Polypodium leucotomos is a fern plant that contains cultivated Polypodium leucotomos extract, which grows exclusively in the Honduran jungles and rain forests. It is being used as a natural food supplement for Psoriasis, Vitiligo, Dermatitis & Multiple Sclerosis.


Reasons taken

9 patients in the community are taking or have taken Kalawalla.

Reason # Patients Percentage of patients
Slow my MS progress 4 44%
Fatigue 1 11%
Everything 1 11%
Other 1 11%
Bladder problems 1 11%

Other treatments patients are taking for Slow my MS progress include Glatiramer acetate, Interferon beta-1a IM Injection, and Interferon beta-1a SubQ injection.

Dosages

Based on the patients currently taking Kalawalla.

  2 mL daily 4 tab(s) daily 800 mg daily 1600 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3  

Duration

How long current patients have been taking Kalawalla or how long patients were taking Kalawalla before stopping.

Currently Taking Kalawalla

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
2
1

Stopped Taking Kalawalla

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
0
1
Why Patients Stopped Taking Kalawalla (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 2 100% Doctor's advice: 100%
Other 1 50% Other: 50%

Patient Reported Evaluations

Results from 3 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 100% 1

Slow my MS progress

Side-effects (as an overall problem)

Severe 0% 0
Moderate 0% 0
Mild 0% 0
None 100% 3

Top reported side-effects include:

Summary results are based on 3 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 3)

  • Valjo
    Sex: F
    Sensation: Moderate
    Overall: Mild
    Cognition: mild
    Vision: moderate
    Speech: none
    Swallowing: mild
    Upper limb: none
    Walking: moderate
  • Valjo
  • by Valjo
    Sep 15, 2008
  • EfficacyMajor
  • Side-effectsNone
  • Excessive daytime sleepiness (somnolence)
Advice/Tips
Has decreased my fatigue. I can stay up later & don't feel so tired al the time. In addition it has improved my sex life.l

See all evaluation results for Kalawalla

Report created on November 07, 2009.